Literature DB >> 23270645

A review of health technology appraisals: case studies in oncology.

Koonal Kirit Shah1, Jorge Mestre-Ferrandiz, Adrian Towse, Emily Nash Smyth.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23270645     DOI: 10.1017/S0266462312000669

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


× No keyword cloud information.
  5 in total

1.  PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH.

Authors:  Rachael Moloney; Penny Mohr; Emma Hawe; Koonal Shah; Martina Garau; Adrian Towse
Journal:  Int J Technol Assess Health Care       Date:  2015-01       Impact factor: 2.188

2.  The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries.

Authors:  Sarah Kleijnen; Teresa Leonardo Alves; Kim Meijboom; Iga Lipska; Anthonius De Boer; Hubertus G Leufkens; Wim G Goettsch
Journal:  Qual Life Res       Date:  2017-04-11       Impact factor: 4.147

3.  Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries.

Authors:  Elena Nicod
Journal:  Eur J Health Econ       Date:  2016-08-18

4.  Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).

Authors:  Martina Garau; Grace Hampson; Nancy Devlin; Nicola Amedeo Mazzanti; Antonio Profico
Journal:  Pharmacoecon Open       Date:  2018-06

Review 5.  A multi-stakeholder approach in optimising patients' needs in the benefit assessment process of new metastatic breast cancer treatments.

Authors:  Fatima Cardoso; Nils Wilking; Renato Bernardini; Laura Biganzoli; Jaime Espin; Kaisa Miikkulainen; Susanne Schuurman; Danielle Spence; Sabine Spitz; Sonia Ujupan; Nicole Zernik; Jenn Gordon
Journal:  Breast       Date:  2020-05-10       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.